IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.199
AS - Asia 8.403
EU - Europa 4.655
SA - Sud America 1.552
AF - Africa 202
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 30.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.947
SG - Singapore 3.944
CN - Cina 1.672
BR - Brasile 1.231
UA - Ucraina 1.062
HK - Hong Kong 856
VN - Vietnam 771
IT - Italia 734
DE - Germania 675
FI - Finlandia 414
RU - Federazione Russa 362
FR - Francia 354
GB - Regno Unito 251
IE - Irlanda 242
SE - Svezia 223
IN - India 202
TR - Turchia 189
BD - Bangladesh 178
CA - Canada 136
AR - Argentina 118
KR - Corea 112
AT - Austria 66
IQ - Iraq 66
JP - Giappone 66
EC - Ecuador 64
ZA - Sudafrica 64
ID - Indonesia 58
MX - Messico 56
NL - Olanda 54
PL - Polonia 44
CO - Colombia 41
PK - Pakistan 35
ES - Italia 32
EG - Egitto 29
UZ - Uzbekistan 29
CZ - Repubblica Ceca 28
IR - Iran 28
BE - Belgio 25
MA - Marocco 25
SA - Arabia Saudita 24
PY - Paraguay 23
CL - Cile 22
VE - Venezuela 22
PH - Filippine 21
TG - Togo 20
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
LT - Lituania 16
JM - Giamaica 13
MY - Malesia 13
AZ - Azerbaigian 12
UY - Uruguay 12
CR - Costa Rica 11
JO - Giordania 11
KZ - Kazakistan 11
OM - Oman 11
DO - Repubblica Dominicana 10
KE - Kenya 10
NP - Nepal 10
PE - Perù 10
PT - Portogallo 10
BO - Bolivia 9
DZ - Algeria 9
GR - Grecia 9
IL - Israele 9
TT - Trinidad e Tobago 9
AL - Albania 7
LB - Libano 7
TH - Thailandia 7
TW - Taiwan 7
EE - Estonia 6
EU - Europa 6
KG - Kirghizistan 6
LK - Sri Lanka 6
RO - Romania 6
BY - Bielorussia 5
HR - Croazia 5
NZ - Nuova Zelanda 5
AU - Australia 4
CH - Svizzera 4
ET - Etiopia 4
PA - Panama 4
BB - Barbados 3
BN - Brunei Darussalam 3
GA - Gabon 3
HN - Honduras 3
KW - Kuwait 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
GT - Guatemala 2
HU - Ungheria 2
Totale 29.988
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Singapore 1.582
Ashburn 1.149
Ann Arbor 1.122
Fairfield 1.061
Houston 979
Beijing 838
Hong Kong 829
Chandler 767
Jacksonville 681
San Jose 564
Wilmington 520
Council Bluffs 462
Seattle 441
Dearborn 415
Boardman 413
Cambridge 335
Lauterbourg 285
Ho Chi Minh City 239
Dublin 238
Los Angeles 230
Princeton 229
Udine 180
Dallas 162
Izmir 138
Hanoi 136
Hefei 129
São Paulo 122
Buffalo 121
Helsinki 107
Seoul 105
Redondo Beach 97
New York 92
Des Moines 85
Dong Ket 80
Santa Clara 80
Munich 79
San Diego 79
Nuremberg 70
The Dalles 70
Ogden 60
Orem 57
Frankfurt am Main 55
Milan 52
Norwalk 50
Ottawa 44
Tokyo 42
London 41
Redmond 41
Warsaw 40
Nanjing 38
Johannesburg 37
Rio de Janeiro 37
Mumbai 35
Trieste 35
Brooklyn 34
Montreal 31
Atlanta 30
Amsterdam 29
Chennai 29
Toronto 29
Belo Horizonte 28
Denver 28
Phoenix 28
Pittsburgh 28
Stockholm 28
Tashkent 28
Da Nang 27
Haiphong 27
Belluno 26
Rome 26
San Mateo 26
Chicago 25
Lappeenranta 25
Düsseldorf 24
Guangzhou 24
Curitiba 23
Vienna 23
Guayaquil 22
Quito 22
Brasília 21
Brno 21
Baghdad 20
Brussels 20
Hải Dương 20
Lomé 20
San Francisco 19
Turku 19
Manchester 18
Mexico City 17
Porto Alegre 17
Salvador 17
Shanghai 17
Biên Hòa 16
Kunming 16
Poplar 16
Auburn Hills 15
Boston 15
Falls Church 15
Lahore 15
Totale 18.632
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 199
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 191
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 186
Validation of the classification criteria for cryoglobulinaemic vasculitis. 183
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 183
Pain management in cryoglobulinaemic syndrome 181
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 181
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 180
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 179
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 178
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 175
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 173
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 171
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 169
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 168
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 167
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 165
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 164
Use of teriparatide in osteoporosis due to active rheumatic diseases 163
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 163
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 162
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 162
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 161
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 160
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 159
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 159
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 157
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 157
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 156
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 155
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 154
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 152
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 151
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 151
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 151
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 150
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 150
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 150
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 150
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 150
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 148
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 148
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 146
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 146
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 146
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 145
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 145
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 144
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 144
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 143
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 143
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 142
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 141
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 140
Classification of cryoglobulinemic vasculitis 139
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 139
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 139
Myositis in primary sjögren's syndrome: data from a multicenter cohort 138
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 138
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 137
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 137
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 137
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 136
Gastrointestinal Involvement in Systemic Vasculitis 135
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 135
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 134
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 132
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 132
Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement 132
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 131
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 131
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 128
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 128
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 127
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 127
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 126
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 126
Post-covid-19 arthritis and sacroiliitis: Natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature 126
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 124
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 124
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 124
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 123
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 123
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 123
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 123
Gastrointestinal involvement in systemic vasculitis 123
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 122
efficacy of methotrexate in polymyalgia rheumatica 122
Preliminary classification criteria for the cryoglobulinaemic vasculitis 122
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 122
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 121
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 121
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 121
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 120
Rituximab for rheumatoid arthritis refractory to both conventional therapy and anti-tumor necrosis factor therapy: results of a multi-centre observational italian studyann 120
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 120
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 120
Chlamydophila psittaci subclinical infection in chronic polyarthritis 119
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 119
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 118
Totale 14.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 0 0 0 0 0 176
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/20255.380 121 403 231 158 236 233 337 358 709 492 771 1.331
2025/202610.440 789 1.026 943 1.044 1.543 919 1.092 391 735 872 837 249
Totale 31.010